Searchable abstracts of presentations at key conferences in endocrinology

ea0014p139 | (1) | ECE2007

Survivin – a promising target for immunotherapy in patients with adrenocortical carcinoma

Fassnacht Martin , Wortmann Sebastian , Sbiera Silviu , Kuehner Dorothee , Wobser Marion , Adam Patrick , Becker Juergen C. , Allolio Bruno

Objectives: Adrenocortical carcinoma (ACC) is a rare tumor with poor prognosis and limited therapeutic options. Survivin is an anti-apoptotic molecule expressed by neoplastic and tumor-specific endothelial cells of various carcinomas, but rarely or only weakly in normal differentiated tissue. In melanoma and pancreatic cancer, preliminary results of a survivin vaccination trial (www.clinicaltrials.gov) indicated that an immunological response in patients is often paralleled by...

ea0049ep692 | Obesity | ECE2017

Hydroxysteroid (17beta) dehydrogenase 13 knockout mice present with inflammation associated liver steatosis

Heikela Hanna , Adam Marion , Portius Dorothea , Maki-Jouppila Jenni , Mehmood Arfa , Adhikari Prem , Esposito Irene , Elo Laura , Zhang Fu-Ping , Ruohonen Suvi T , Strauss Leena , Foti Michelangelo , Poutanen Matti

: Hydroxysteroid (17beta) dehydrogenases (HSD17Bs) form a group of enzymes that are characterized by their sequence similarity at the active site, and their ability to catalyze the conversion between the weak 17keto- and the highly active 17beta-hydroxysteroids. To study the physiological role of HSD17B13, a lipid droplet associated protein, we characterized the phenotype of knockout (KO) mice deficient in HSD17B13 (HSD17B13KO). The data revealed normal serum sex steroid conce...